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A Cotransformation Method To Identify a Restriction-Modification
Enzyme That Reduces Conjugation Efficiency in Campylobacter jejuni
Abstract
Conjugation is an important mechanism for horizontal gene transfer in Campylobacter jejuni, the leading
cause of human bacterial gastroenteritis in developed countries. However, to date, the factors that significantly
influence conjugation efficiency in Campylobacter spp. are still largely unknown. Given that multiple
recombinant loci could independently occur within one recipient cell during natural transformation, the
genetic materials from a high-frequency conjugation (HFC) C. jejuni strain may be cotransformed with a
selection marker into a low-frequency conjugation (LFC) recipient strain, creating new HFC transformants
suitable for the identification of conjugation factors using a comparative genomics approach. To test this, an
erythromycin resistance selection marker was created in an HFC C. jejuni strain; subsequently, the DNA of
this strain was naturally transformed into NCTC 11168, an LFC C. jejuni strain, leading to the isolation of
NCTC 11168-derived HFC transformants. Whole-genome sequencing analysis and subsequent site-directed
mutagenesis identified Cj1051c, a putative restriction-modification enzyme (aka CjeI) that could drastically
reduce the conjugation efficiency of NCTC 11168 (>5,000-fold). Chromosomal complementation of three
diverse HFC C. jejuni strains with CjeI also led to a dramatic reduction in conjugation efficiency
(∼1,000-fold). The purified recombinant CjeI could effectively digest the Escherichia coli-derived shuttle
vector pRY107. The endonuclease activity of CjeI was abolished upon short heat shock treatment at 50°C,
which is consistent with our previous observation that heat shock enhanced conjugation efficiency in C.
jejuni. Together, in this study, we successfully developed and utilized a unique cotransformation strategy to
identify a restriction-modification enzyme that significantly influences conjugation efficiency in C. jejuni.
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ABSTRACT Conjugation is an important mechanism for horizontal gene transfer
in Campylobacter jejuni, the leading cause of human bacterial gastroenteritis in
developed countries. However, to date, the factors that signiﬁcantly inﬂuence
conjugation efﬁciency in Campylobacter spp. are still largely unknown. Given that
multiple recombinant loci could independently occur within one recipient cell
during natural transformation, the genetic materials from a high-frequency con-
jugation (HFC) C. jejuni strain may be cotransformed with a selection marker into
a low-frequency conjugation (LFC) recipient strain, creating new HFC transfor-
mants suitable for the identiﬁcation of conjugation factors using a comparative
genomics approach. To test this, an erythromycin resistance selection marker
was created in an HFC C. jejuni strain; subsequently, the DNA of this strain was
naturally transformed into NCTC 11168, an LFC C. jejuni strain, leading to the iso-
lation of NCTC 11168-derived HFC transformants. Whole-genome sequencing
analysis and subsequent site-directed mutagenesis identiﬁed Cj1051c, a putative
restriction-modiﬁcation enzyme (aka CjeI) that could drastically reduce the conju-
gation efﬁciency of NCTC 11168 (5,000-fold). Chromosomal complementation
of three diverse HFC C. jejuni strains with CjeI also led to a dramatic reduction in
conjugation efﬁciency (1,000-fold). The puriﬁed recombinant CjeI could effec-
tively digest the Escherichia coli-derived shuttle vector pRY107. The endonuclease
activity of CjeI was abolished upon short heat shock treatment at 50°C, which is
consistent with our previous observation that heat shock enhanced conjugation
efﬁciency in C. jejuni. Together, in this study, we successfully developed and uti-
lized a unique cotransformation strategy to identify a restriction-modiﬁcation en-
zyme that signiﬁcantly inﬂuences conjugation efﬁciency in C. jejuni.
IMPORTANCE Conjugation is an important horizontal gene transfer mechanism
contributing to the evolution of bacterial pathogenesis and antimicrobial resis-
tance. Campylobacter jejuni, the leading foodborne bacterial organism, displays
signiﬁcant strain diversity due to horizontal gene transfer; however, the molecu-
lar components inﬂuencing conjugation efﬁciency in C. jejuni are still largely un-
known. In this study, we developed a cotransformation strategy for comparative
genomics analysis and successfully identiﬁed a restriction-modiﬁcation enzyme
that signiﬁcantly inﬂuences conjugation efﬁciency in C. jejuni. The new cotrans-
formation strategy developed in this study is also expected to be broadly ap-
plied in other naturally competent bacteria for functional comparative genomics
research.
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Campylobacter jejuni is a leading bacterial cause of human gastroenteritis in theUnited States and developed countries. C. jejuni infection may also result in
long-lasting sequelae, such as irritable bowel syndrome (1), reactive arthritis (2), and
even the life-threatening Guillain-Barré syndrome (3–6). Campylobacter is highly prev-
alent in food-producing animals; contaminated poultry meat is the major risk factor for
human campylobacteriosis (7, 8). However, to date, there are still no effective inter-
vention strategies to prevent and control Campylobacter infections in humans and
animal reservoirs (8, 9), partly due to the signiﬁcant genome plasticity and strain
diversity observed in C. jejuni.
Horizontal gene transfer (HGT) plays a critical role in bacterial diversity, consequently
contributing to bacterial evolution and adaptation in different environmental niches
(10). Of the three general HGT mechanisms in bacteria (natural transformation, conju-
gation, and transduction) (11, 12), natural transformation has been well documented in
C. jejuni (8, 13–18). However, information concerning conjugation, an important mech-
anism for the dissemination of antibiotic resistance and virulence factors, is still very
limited in C. jejuni (19–22).
In our previous study, we observed that a simple heat shock treatment drastically
enhanced conjugation efﬁciency in the standard C. jejuni NCTC 11168 and 81-176
strains, which display low-frequency conjugation (LFC) (23). This ﬁnding indicates the
existence of a genetic determinant controlling conjugation efﬁciency in C. jejuni;
however, the underlying molecular basis is still unknown after ruling out several factors,
such as secreted substances, CRISPR, and selected restriction-modiﬁcation components
(23). In the same study, we also observed that some C. jejuni strains, such as CG8486,
displayed extremely high-frequency conjugation (HFC) as a recipient strain compared
to the LFC NCTC 11168 and 81-176 strains (23). Despite the availability of the whole-
genome sequences of these C. jejuni strains, there exist great differences in their
genetic background, which make it very challenging to identify the factor(s) controlling
conjugation efﬁciency using a comparative genomics approach. For example, a pre-
liminary genome comparison between NCTC 11168 and CG8486 revealed 106 different
genes (24).
A well-recognized feature of C. jejuni is its high efﬁciency in natural transformation,
a process widely observed in different bacteria to directly take up foreign DNA in the
environment (11). With the aid of next-generation sequencing and comparative
genomics technologies, recent natural transformation studies in different bacterial
organisms (25, 26) have demonstrated that multiple recombination loci occurred
independently (or cotransformed) within one recipient cell during natural transforma-
tion. This ﬁnding prompted us to speculate that some unique genetic materials from an
HFC donor strain could be cotransformed together with a selection marker into an LFC
recipient strain, consequently creating HFC transformants either through a knock-in or
knockout mechanism; the new HFC transformants and LFC strain with the same genetic
background can be used for efﬁcient identiﬁcation of conjugation factors using a
comparative genomics approach. In this study, we developed a two-step cotransfor-
mation method with incorporation of an enrichment step for successful identiﬁcation
and characterization of a restriction-modiﬁcation enzyme (Cj1051c, or CjeI) contributing
to conjugation efﬁciency in Campylobacter jejuni.
RESULTS
ChuB mutation did not affect the conjugation efﬁciency in C. jejuni CG8486.
The isogenic chuB::erm mutant (JL1126, Table 1) was successfully generated. This strain
contains an erythromycin resistance (Eryr) selection marker in the HFC strain CG8486.
The wild-type CG8486 and the chuB::erm mutant displayed similar conjugation efﬁ-
ciency, at (1.5  1.0)  104 CFU/recipient and (1.0  0.02)  104 CFU/recipient,
respectively, as determined using the biparental conjugation method reported previ-
ously (23). Therefore, the isogenic chuB mutant of CG8486, which not only displays an
HFC phenotype as its parent strain but also carries an Eryr selection marker, was suitable
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to serve as a genomic DNA donor for the two-step cotransformation approach used in
this study.
Two-step screening of the transformants with high-frequency conjugation. In
the ﬁrst step of screening (natural transformation), the Eryr transformants, which
resulted from transformation of the chuB::erm, should be cotransformed with other
variable regions (likely including those related to HFC) from the donor CG8486 (see Fig.
1A). If the Eryr transformant library contains a population with an HFC phenotype, the
pooled Eryr transformants were expected to generate more progenies when serving as
a recipient for conjugation. Compared to the conjugation using the LFC NCTC 11168
strain, the pooled Eryr transformant population displayed approximately 10-fold higher
conjugation efﬁciency (data not shown), leading to the selection of 22 Eryr kanamycin-
TABLE 1 Bacterial plasmids and strains used in this study
Plasmid or strain Descriptiona Source or reference
Plasmids
pGEM-T Cloning vector, Ampr Promega
pUC19 Cloning vector, Ampr New England BioLabs
pRY107 E. coli-C. jejuni shuttle vector, Kanr 39
RK212.1 Helper plasmid for biparental conjugation 40
pCjR pUC19 derivative containing C. jejuni ribosomal site, Ampr This study
PCjR-MCS pCjR derivative with MCS, Ampr This study
pRO pCjR-MCS derivative with Cj0299 overexpression promoter, Ampr This study
pROC pRO derivative with chloramphenicol resistance marker, Ampr Cmr This study
pROC-CjeI pROC derivative with CjeI ORF (rrs::cjeI-cat), Ampr Cmr This study
pET-21b C-6His fusion recombinant protein expression vector, Ampr Novagen
pET-28b N-6His and C-6His fusion protein expression vector, Kanr Novagen
pChuB::erm pUC19 derivative, suicidal vector This study
pCjeI::cat pUC19 derivative, suicidal vector This study
pET21b-CjeI Expression construct of CjeI fused with C-6His This study
pET28b-CjeI Expression construct of CjeI fused with double 6His This study
Strains
C. jejuni
JL241 NCTC 11168, wild type, LFC 38
JL686 CG8486, wild type, with HFC 24
JL1126 CG8486, Eryr (chuB::erm), HFC This study
JL1128 NCTC 11168, Eryr transformant 1, HFC, sequenced This study
JL1129 NCTC 11168, Eryr transformant 11, HFC This study
JL1130 NCTC 11168, Eryr transformant 12, HFC, sequenced This study
JL1131 NCTC 11168, Eryr transformant 13, HFC This study
JL1132 NCTC 11168, Eryr transformant 14, HFC, sequenced This study
JL1133 NCTC 11168, Eryr transformant 17, HFC, sequenced This study
JL1134 NCTC 11168, Eryr transformant 18, HFC This study
JL1135 NCTC 11168, Eryr transformant 19, HFC, sequenced This study
JL1136 NCTC 11168, Eryr transformant 20, LFC, sequenced This study
JL1137 NCTC 11168, Eryr transformant 21, HFC, sequenced This study
JL1138 NCTC 11168, Eryr transformant 22, LFC, sequenced This study
JL1341 CG8486, rrs::cjeI-cat This study
JL1345 NCTC 11168, Eryr transformant 11, rrs::cjeI-cat This study
JL1347 NCTC 11168, Eryr transformant 12, rrs::cjeI-cat This study
JL1160 NCTC 11168, cjeI::cat This study
E. coli
BL21(DE3) fhuA2 [lon] ompT gal (DE3) [dcm] ΔhsdS; DE3   sBamHIo
ΔEcoRI-B int::(lacI::PlacUV5::T7 gene 1) i21 Δnin5
New England BioLabs
DH5 F 80lacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 hsdR17(rK
mK	) phoA supE44 thi-1 gyrA96 relA1 
Invitrogen
TOP10 F mcrA Δ(mrr-hsdRMS-mcrBC) 80lacZΔM15 ΔlacX74 recA1
araD139 Δ(ara leu)7697 galU galK rpsL (Strr) endA1 nupG
Invitrogen
JL837 TOP10/pChuB::erm This study
JL1116 DH5/RK212.1/pRY107; donor strain for biparental conjugation 23
JL1159 TOP10/pCjeI::cat This study
JL1165 BL21(DE3)/pET21b-CjeI, Ampr This study
JL1166 BL21(DE3)/pET28b-CjeI, Kanr, recombinant CjeI expression This study
aAmpr, ampicillin resistant; MCS, multiple-cloning site; Cmr, chloramphenicol resistant; Strr, streptomycin resistant.
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resistant (Kanr) transconjugants with potential HFC phenotype acquired, which were
observed on the plates with a conjugation mix at higher dilution.
To validate acquisition of the HFC phenotype in these 22 transconjugants, the
conjugatively transferred pRY107 plasmid was cured from each potential HFC transcon-
jugant, and the corresponding parental Eryr transformant was tested again for conju-
gation efﬁciency. A total of 9 transformants (no. 1, 11, 12, 13, 14, 17, 18, 19, and 21) were
conﬁrmed to have an HFC phenotype (5  105 transconjugant CFU/recipient cell).
Other transformants, such as transformants 20 and 22, displayed an LFC phenotype
similar to that of the parental strain NCTC 11168 at a conjugation level of 
5  107
FIG 1 Identiﬁcation and characterization of HFC transformants from C. jejuni NCTC 11168 using a two-step
cotransformation strategy. (A) Schematic diagram of the two-step screening based on natural transformation. The
donor genomic DNA from CG8486 with Eryr marker (chuB::erm, solid triangle) is used to transform NCTC 11168 with
LFC phenotype. Variable regions (open rectangles), including the desired HFC factor (HFCF, solid circle), in the
genome of C. jejuni CG8486 can be cotransformed with the Eryr marker (solid triangle). All the Eryr transformants
are pooled and used as recipient for conjugation, together with the donor JL1116 containing shuttle vector pRY107
(Table 1); the LFC strain NCTC 11168 is used as a control recipient. Based on the difference in transconjugant
emergence pattern, potential HFC transconjugants containing pRY107 (open oval) are obtained; the transconju-
gants with cured plasmid are used as recipient for conjugation to validate the HFC phenotype. Strains A1 and A5
are conﬁrmed to be real HFC strains which originated from the same parent strain. Whole-genome sequencing and
comparative genomics analysis identify the putative HFCF from the HFC CG8486 (within the dashed box). (B) The
representative screening result showing the dramatic difference in conjugation efﬁciency when using the NCTC
11168 (left) and its derivative HFC transformant strain 1 (right) as a recipient. The undiluted conjugation mixture
was spread on a selective plate. Compared to very limited transconjugants resulting from NCTC 11168 (left), large
quantities of transconjugants were generated by using the HFC transformant strain 1 (3,000-fold) (right).
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transconjugant CFU/recipient cell (Fig. 2A). Therefore, using this unique two-step
screening method, the plasmid-free Eryr derivatives of NCTC 11168 that displayed an
HFC phenotype were successfully obtained (Fig. 2A).
Comparative genomic analysis among HFC, LFC, and NCTC 11168 reference
genome sequences. A total of 6 HFC transformants (no. 1, 12, 14, 17, 19, and 21) and
2 LFC transformants (no. 20 and 22) were used for genome sequencing and compar-
FIG 2 Identiﬁcation of CjeI as a limiting factor for conjugation. (A) Conjugation efﬁciency of representative Eryr transformants with potential HFC efﬁciency. Each
bar represents mean of the results from two independent experiments, with duplicate measurements for each experiment. (B) Comparison of CjeI locus
between C. jejuni NCTC 11168 and CG8486. The CjeI gene in C. jejuni NCTC 11168 is replaced by a two-gene operon in strain CG8486. (C) PCR analysis
of CjeI locus. Two LFC transformants (20 and 22) and validated HFC transformants (1, 11, 12, 13, 14, 17, 18, 29, and 21) were used for PCR analysis. The
length of corresponding PCR product at CjeI locus is 5,539 bp in NCTC 11168 and 3,471 bp in CG8486. (D) The effect of CjeI mutation on conjugation
efﬁciency. The open bar denotes the heat shock untreated control, while the solid black bar denotes the recipient cells that were heat shocked at 50°C
for 30 min. Each bar represents mean of the results from two independent experiments, with duplicate measurements for each experiment. The asterisk
denotes statistically signiﬁcant difference (P 
 0.05).
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ative genomics analysis. Paired-end sequencing of these transformants in the Illumina
MiSeq version 2 platform resulted in 200-fold genome coverage for each strain. De
novo-assembled draft genome sequences from HFC and LFC transformants are
compared with C. jejuni NCTC 11168. An initial examination (Table 2) revealed that
two single-nucleotide polymorphisms (SNPs) were present in all HFC strains but
absent from the two LFC strains. Based on annotation, the two SNPs, C¡T at CheA
and poly(C)10¡poly(C)11 at Cj1429c, probably did not cause HFC. For example, the
(C)10¡poly(C)11 SNP might be due to a sequencing or assembly error.
Further analysis identiﬁed one gene replacement in which a two-gene operon from
CG8486 replaced Cj1051c (CjeI) in two HFC transformants (no. 14 and 17; Fig. 2B). It is
interesting that Cj1051c is annotated as a unique restriction enzyme that recognizes
asymmetrical interrupted sequences (27) and is reported to be a restriction barrier of
NCTC 11168 for plasmid transformation (28). PCR analysis conﬁrmed that the gene
replacement at the CjeI locus occurs in most (5 out of 9) HFC transformants (Fig. 2C) but
is absent from all LFC transformants (data not shown). Therefore, the gene replacement
at the CjeI locus is highly associated with the HFC phenotype.
Inactivation of CjeI increased conjugation efﬁciency and diminished the heat
shock-enhanced conjugation. The comparative genomic analysis indicated that the
LFC phenotype might be attributed to the function of CjeI. To test this, CjeI was
inactivated in the LFC strain NCTC 11168. As shown in Fig. 2D, compared with wild-type
NCTC 11168, the isogenic CjeI mutant displayed drastically increased conjugation
efﬁciency to a level that is comparable to that of the HFC strain CG8486 (104
CFU/recipient cell).
Since we have observed that heat shock treatment drastically enhanced conjugation
efﬁciency in NCTC 11168 (23), we further investigated if this phenotype is mediated
through CjeI. As observed in a previous study (23), heat shock treatment of NCTC 11168
recipient cells led to an approximately 100-fold increase in conjugation efﬁciency (Fig.
2D). However, the CjeI mutant displayed a dramatic reduction in heat shock-enhanced
conjugation, only resulting in an approximately 4.4-fold increase in conjugation efﬁ-
ciency (Fig. 2D). Together, these ﬁndings indicated CjeI is a limiting factor for the
efﬁciency of conjugation in Campylobacter spp. and is also a major player involved in
the heat shock-enhanced conjugation in LFC strains observed in a recent study (23).
Chromosomal complementation of CjeI in HFC strains decreased conjugation
efﬁciency. The above-described CjeI inactivation experiment could not exclude the
possibility of the polar effect caused by the insertion of chloramphenicol resistance
marker cat. To further validate the role of CjeI in conjugation, CjeI was introduced into
three HFC strains via chromosomal complementation. To perform chromosomal com-
plementation, a new chromosomal integration vector, pROC, was created (Fig. 3A),
which facilitates the addition of essential components (such as the appropriate pro-
moter and selection marker) for gene expression at a ribosomal site. As shown in Fig.
3B, the introduction of CjeI in three HFC strains (CG8486, transformants 11 and 12)
drastically decreased the conjugation efﬁciency (1,000-fold reduction) to a level that
was close to that of the LFC strain NCTC 11168 (
2 107 CFU/recipient cell). Of note,
transformant 12 possesses CjeI but displayed the HFC phenotype. The complementa-
tion of CjeI could abolish the HFC phenotype, indicating that CjeI in transformant 12
might not be appropriately expressed or functional. Further analysis of assembled
contigs of HFC transformant 12 revealed a C¡T mutation at bp 929 of the predicted
TABLE 2 Comparative analysis between HFC and LFC strains
Gene Position(s)a Change (HFC¡LFC) Annotation/function
Cj0284c (CheA) 261112 T¡C Chemotaxis histidine kinase
Cj1429c 1363822 10C¡11C Hypothetic protein
Cj1051c (CjeI) 982991–987010 Replaced by an
operon
Restriction-modiﬁcation enzyme
aCoordinate position corresponding to the reference genome of NCTC 11168.
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CjeI open reading frame (ORF), resulting in a GCT (Ala) to GTT (Val) mutation. Interest-
ingly, this mutation was also observed in two other HFC transformants (no. 19 and 21). The
assembled contigs of HFC transformant 1 showed another type of mutation, a T missing at
bp 3455 of the predicted CjeI ORF, indicating a frameshift mutation. Therefore, those CjeI
gene-containing HFC transformants (no. 1, 12, 19, and 21) all have a point mutation in the
ORF of CjeI which is not observed in LFC transformants (20 and 22).
Expression and puriﬁcation of rCjeI. In this study, we generated two recombinant
strains, JL1165 and JL1166 (Table 1), that produce C-terminal His-tagged recombinant
CjeI (rCjeI) and double His-tagged rCjeI, respectively. Upon induction by isopropyl
thio--D-galactopyranoside (IPTG) at a ﬁnal concentration of 0.5 mM at 37°C for 3 h, the
rCjeI with 6His tag at both the N terminus and C terminus was induced to a
signiﬁcantly higher level in JL1166 than the production of the rCjeI with C-terminal
6His tag alone in JL1165 (data not shown). Therefore, the JL1166 construct was
chosen for rCjeI puriﬁcation. However, the growth of JL1166 at 37°C led to almost all of
rCjeI going to the inclusion body. Although Empigen BB (Sigma, St. Louis, MO), a mild
detergent, has been successfully used for the solubilization of functional His-tagged
recombinant proteins from inclusion bodies in our previous studies (29–31), in this
study, we failed to solubilize rCjeI from the inclusion body using Empigen BB (data not
shown). Subsequently, we examined the production of rCjeI under various conditions
and successfully expressed soluble rCjeI by growing cells at low temperature (4°C) with
a long induction time (72 h) using a low concentration of IPTG (0.1 mM). As shown in
FIG 3 Chromosomal complementation of CjeI. (A) Schematic diagram of the chromosomal integration vector. The
ribosomal fragment (rrs) from C. jejuni NCTC 11168 was cloned into NdeI/SphI-digested pUC19 to generate the
plasmid pCjR. The fragment containing multiple cloning sites (indicated in ﬁgure) was subsequently introduced
into pCjR, generating pCjR-MCS (Table 1), which facilitates downstream gene cloning. The overexpression promoter
of Cj0299 (50) and chloramphenicol resistance marker cat were then incorporated into pCjR-MCS, leading to a new
chromosomal integration vector, pROC (Table 1). The cjeI gene was ﬁnally cloned into pROC, generating the suicide
vector pROC-CjeI (Table 1) for chromosomal complementation of cjeI. CjeI_Seq_F and Cm_Seq_R were used to
conﬁrm the integration of the complementation construct in the chromosome. (B) Conjugation efﬁciency of HFC
strains with or without chromosomal complementation of CjeI. Besides the CG8486 wild type (CjeI gene-lacking),
two representative HFC transformants, transformant 11 (CjeI gene-lacking) and transformant 12 (CjeI gene-
containing), were also complemented with the CjeI gene (rrs::cjeI-cat). Each bar represents mean of triplicate
measurements.
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Fig. 4A, the rCjeI with an approximate molecular mass of 157 kDa was signiﬁcantly
induced by a low concentration of IPTG by 24 h, and the production level continued
to increase by 72 h postinduction. Approximately 50% of rCjeI was distributed in the
soluble fraction. Finally, soluble rCjeI was successfully puriﬁed using nickel-
nitrilotriacetic acid (Ni-NTA) afﬁnity chromatography (Fig. 4A). The yield of rCjeI is
approximately 1.8 mg/liter culture.
rCjeI displayed endonuclease activity. The CjeI is annotated as a type I restriction-
modiﬁcation enzyme. Given that the inactivation of CjeI drastically enhanced conjuga-
tion efﬁciency (Fig. 2D), we speculated that CjeI has endonuclease activity by digesting
the pRY107 from E. coli DH5 effectively. As shown in Fig. 4B, in the absence of rCjeI
(0 min), most pRY107 are in the supercoil form (a sharp bright band in the front).
However, after being incubated with rCjeI for as short as 5 min, the pRY107 plasmid
DNA consistently showed a low migration rate, indicating that plasmids became nicked
and/or linearized. This ﬁnding demonstrated that CjeI possesses endonuclease activity
on the pRY107 from E. coli DH5.
rCjeI is heat labile. Based on above-mentioned ﬁnding that the heat shock-
enhanced conjugation efﬁciency is primarily dependent on CjeI, we speculated that the
endonuclease activity of CjeI can be greatly reduced upon temporary heat shock
treatment. To test this, the thermostability of CjeI on the endonuclease activity was
further examined in this study. As shown in Fig. 4C, temporary heat treatment of rCjeI
at 50°C for as short as 5 min completely abolished its endonuclease activity, reﬂected
by the same plasmid proﬁle as that for the original pRY107. Only the rCjeI without heat
treatment hydrolyzed pRY107 (Fig. 4C, third lane from left).
DISCUSSION
It is well known that the delivery of a heterogeneous shuttle vector into C. jejuni host
is frustrating, whether using natural transformation, electroporation, or conjugation
approaches, and it has become a hurdle for scientists to perform molecular manipulation
for C. jejuni. Although C. jejuni strains are naturally competent, the shuttle vector derived
from different species (e.g., E. coli) is still very difﬁcult to be directly transformed into a C.
jejuni host strain (13, 26), likely due to the presence of powerful restriction-modiﬁcation
systems in C. jejuni. To address this challenge, some natural transformation-based gene
delivery approaches, such as chromosomal integration at ribosomal (32) or pseudogene
(33) sites, have been developed; however, these approaches require complicated molecular
FIG 4 Functional characterization of CjeI. (A) SDS-PAGE analysis of rCjeI production and puriﬁcation. The E. coli JL1166 was grown at 4°C for 72 h upon induction
by a low concentration of IPTG (0.1 mM). The samples used for SDS-PAGE analysis include a whole-cell lysate of noninduced E. coli (0 h), whole-cell lysate of
E. coli induced by IPTG at different time points (24, 48, and 72 h), and the soluble, insoluble, and eluted fractions during puriﬁcation using Ni-NTA afﬁnity
chromatography. (B) Endonuclease activity analysis. The pRY107 extracted from E. coli DH5 was digested by rCjeI. The reaction mixture was sampled at
different time points and subjected to DNA agarose gel (0.8%) electrophoresis. (C) The effect of heat shock on the activity of rCjeI. The rCjeI was heat shocked
for different times (5, 15, 30, 45, and 60 min), followed by reaction with substrate DNA (pRY107) for 30 min. The reaction mixture without rCjeI (no rCjeI) and
the mixture containing heat shock untreated rCjeI (no HS) were used as control. Samples were analyzed using agarose gel (0.8%) electrophoresis. HS, heat shock.
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manipulation. Thus, triparental or biparental conjugation has been widely used to deliver
desired plasmids into the C. jejuni host. However, as observed in many laboratories and as
reported in our recent study (23), different C. jejuni strains displayed drastic differences
in the efﬁciency to acquire plasmid via conjugation. In particular, some commonly used
standard C. jejuni strains, such as NCTC 11168, displayed extremely low conjugation
efﬁciency. Recently, we have established a convenient heat shock protocol to enhance
the conjugation efﬁciency of C. jejuni; however, several attempts to explore underlying
molecular mechanisms were not successful (23).
In this study, a delicate two-step cotransformation approach was designed to
identify the factors involved in conjugation in C. jejuni using a comparative genomics
approach. The idea of cotransformation of potential conjugation-associated compo-
nents with a selective marker was inspired by recent in-depth genomics studies on the
mechanism of natural transformation (25, 26). These studies revealed that each trans-
formant clone contains 1,000 donor polymorphisms in 3 to 6 contiguous runs (with the
length of 8.16  4.5 kb), which means the cotransfer of multiple genetic fragments
from donor DNA can occur within every single transformant cell. On the basis of this
evidence, therefore, the screening based on an Eryr selection marker (chuB::erm in this
case) could generate a pool of transformants in which a variety of other donor DNA
fragments (including the genetic determinant of interest) were expected to be intro-
duced as well. In addition, each Eryr transformant colony obtained from nature trans-
formation represents an enriched population of speciﬁc transformant cells; the pooled
transformants with an enriched population are suitable for a comparative conjugation
assay, which has been demonstrated in this study.
A restrictive component, CjeI, contributing to C. jejuni conjugation was successfully
identiﬁed and characterized in this study. Based on annotation, CjeI belongs to the
unusual restriction endonuclease, which requires S-adenosyl-L-methionine for endonu-
clease activity and can recognize interrupted sequence and asymmetrically cut the DNA
(27). In a random transposon mutagenesis study (28), CjeI was identiﬁed as the
restriction barrier to the transformation of a C. jejuni-derived plasmid into C. jejuni NCTC
11168. However, in the same study, the E. coli-derived plasmid was still very difﬁcult to
be transformed into the isogenic CjeI mutant of NCTC 11168, indicating that other
restriction component(s) may be actively involved in the transformation process. In our
study, a CjeI mutation could result in thousands-fold increase in conjugation efﬁciency
when using E. coli DH5 as the conjugative donor, indicating that CjeI is a major
limiting factor for conjugation in NCTC 11168. In addition, using puriﬁed rCjeI in
conjunction with an in vitro endonuclease activity assay, we also demonstrated that CjeI
is very sensitive to temporary heat shock treatment (at 50°C for 5 min); this ﬁnding is
consistent with the fact that the heat shock-enhanced conjugation is primarily medi-
ated through CjeI (Fig. 2D). Previous studies also showed that a heat-labile restriction-
modiﬁcation enzyme system was responsible for the heat-enhanced conjugation in
Corynebacterium glutamicum (34, 35).
Clearly, CjeI is not the sole genetic determinant signiﬁcantly affecting conjugation
efﬁciency in C. jejuni, because conjugation is a complex process in which many factors
are involved. In this study, we observed that heat shock treatment of the CjeI mutant
still led to an approximately 4-fold increase in conjugation efﬁciency (Fig. 2D), suggest-
ing the existence of another heat-labile restriction system to limit conjugation in C.
jejuni. In addition, with respect to our screening, a total of nine transformants were
conﬁrmed to have an HFC phenotype (Fig. 2A). However, only ﬁve transformants (11,
13, 14, 17, and 18) have a gene replacement in the CjeI locus resulting from the
knockout mechanism of our approach, leading to the characterization of CjeI in this
study. Notably, as discussed above, the cotransformation strategy used in this study
also has a knock-in feature. Therefore, the other four HFC transformants (no. 1, 11, 19,
and 21), which are CjeI positive, may have acquired unique determinant(s) from HFC
donor DNA; However, we also observe single nucleotide mutations in these four CjeI
gene-containing but HFC strains. Furthermore, the introduction of CjeI in transformant
12 by chromosomal complementation drastically decreased conjugation efﬁciency
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(Fig. 3), indicating low CjeI activity in these four transformants. Therefore, we could not
completely rule out the possibility that CjeI could not express or function appropriately
in these four HFC strains. The identiﬁcation of new determinants in these transformants
needs further in-depth sequence analysis and molecular characterization. Finally, we
speculate that the unique cotransformation approach used in this study could be used
for the functional genomics study of many other bacterial organisms with high efﬁ-
ciency in natural transformation, such as Helicobacter pylori, Haemophilus inﬂuenzae,
and Vibrio cholerae (15, 36, 37).
MATERIALS AND METHODS
Bacterial strains, plasmids, and culture conditions. The major bacterial strains and plasmids used
are summarized in Table 1. The human isolates NCTC 11168 (38) and CG8486 (24) were characterized in
a previous study (23) and used in this study. The C. jejuni strains were grown routinely in Mueller-Hinton
(MH) broth or on agar at 42°C in Heracell 150i tri-gas incubator (85% N2, 10% CO2, 5% O2; Thermo
Scientiﬁc). An E. coli donor strain containing both transmissible plasmid pRY107 (39) and helper plasmid
RK212.1 (40) for biparental conjugation was constructed in a previous study (23). E. coli strains were
grown routinely in Luria-Bertani (LB) broth with shaking (250 rpm) or on agar at 37°C (for cloning
purpose) or 4°C (for expression of recombinant protein). When needed, culture media were supple-
mented with ampicillin (100 g/ml), kanamycin (50 g/ml), tetracycline (12.5 g/ml), or/and chloram-
phenicol (20 and 6 g/ml for E. coli and C. jejuni, respectively).
Construction of isogenic chuB::erm mutant. ChuB is prevalent in different C. jejuni strains (41) and
was inactivated by insertion of the erythromycin resistance cassette erm (42). In brief, a 2.1-kb PCR
fragment was ampliﬁed from C. jejuni NCTC 11168 using the ChuB_F/ChuB_R primer pair (Table 3) with
Taq enzyme (Promega), which was further puriﬁed and ligated to pGEM-T Easy vector (Promega). The
recombinant plasmid was subsequently digested with SwaI (NEB). Then, the vector backbone was ligated
with the blunt-end erm PCR product that was used in our previous study (42). Approximately 200 ng of
the resulting suicide vector was then introduced into high-frequency conjugation strain C. jejuni CG8486
TABLE 3Major primers used in this studya
Primer DNA sequence (5=–3=)
Product size
(bp)b Target gene and function
ChuB_F GATGATTTTTGGTGGGATTTTT 2,063 Amplify chuB fragment
ChuB_R TTTAAATCAAGGGCTGAAGTGG
Erm_PacI_F CCCTTAATTAAAGCTTTGGCTAACACACACG 1,140 Erythromycin resistance cassette
Erm_PacI_R CCCTTAATTAAAATAGGTACACGAAAAACAAGTTAAGG
CjeI_F GGAGCAAAACGAAGAATTGC 4,627 CjeI fragment from C. jejuni NCTC
11168CjeI_R CAGAGCAAACCTCCATCACA
CjeI_F1 GCAATCCGCAAAATGAAACT 418 Detect insertional mutation
CjeI_R1 TTTGCATATCTTGCCACTCC
Cm_PacI_F CCCTTAATTAATGCTCGGCGGTGTTCCTTT 801 Chloramphenicol resistance cassette
Cm_PacI_R CCCTTAATTAAGCGCCCTTTAGTTCCTAAAG
Cm_F (MfeI) GAGCAATTGTGCTCGGCGGTGTTCCTTT 801 Chloramphenicol resistance cassette
Cm_R (MfeI) GAGCAATTGGCGCCCTTTAGTTCCTAAAG
CjeI_F2 AAAAAGAATCAAACATTACCATCTTTC 5,539 (NCTC
11168)




rrsF (NdeI) GGAATTCCATATGCTGGAACTCAACTGACGCTAAG 1,900 rRNA gene
rrsR (SphI) ACATGCATGCCTCTTGCACATTGCAGTCCTAC
pCjR_MCS_F1 CTAGAGAATTCGAGCTCGGTACCGGATCCGTCGACCTGCAGAGCGCTC 42 Introduce MCS sites into pCjR
pCjR_MCS_R1 AATTGAGCGCTCTGCAGGTCGACGGATCCGGTACCGAGCTCGAATTCT
Cj0299_pMW10_F (XbaI) TGCTCTAGAACTTTTTCTCATTTTGCATACCTCA 280 Cj0299 overexpression promoter
Cj0299_pMW10_R1 (KpnI) CGGGGTACCGCCCAAACACTAAATTTAAGAAAA
CjeI_F4 (KpnI) CGGGGTACCATCAATCAAGGTGGCTTTGG 4,146 Cloning whole ORF of CjeI
CjeI_R4 (BamHI) CGCGGATCCAACCCGCTCCGCTTAATATC
rrs_Seq_F TCACTCGAAGCCGGAATACT 231 Conﬁrm cloning within the
ribosomal site
rrs_Seq_R CAGCTGAGCTAATTCCCCATA
CjeI_F5 (NdeI) GGAATTCCATATGATGATTACAAAAGATAATTTAAAACAAGTTC 4,017 Generate rCjeI expression construct
CjeI_R5 (SalI) GCGCATGTCGACAGAAAATAAATATTTTTGCAAGATTTTTTC
CjeI_F_Seq AACATAGGTTTTGGTAGCACAGAA Detect cloning of CjeI in suicidal
vector
Cm-Seq_R CAGGGCGTATTGCCAAAATA Detect cat insertion in CjeI mutant
aRestriction sites are underlined in the primer sequence and the names are identiﬁed in parentheses.
bSize of amplicon in different strains. The strain name is in parentheses.
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through electroporation (43). Transformants were selected on an MH plate containing 5 g/ml eryth-
romycin (Ery), and the insertional mutation was conﬁrmed by PCR using the chuB_F/Erm_seq_R primer
pair (Table 3).
Two-step screening of transformants with HFC phenotype. The schematic diagram of the
two-step screening of the transformants with HFC is partly shown in Fig. 1A.
Step 1, natural transformation. The genomic DNA of the isogenic CG8486 chuB::erm mutant was
extracted using the Wizard genomic DNA puriﬁcation kit (Promega). Approximately 4 g of genomic
DNA was used for natural transformation using the LFC strain NCTC 11168 as the recipient strain, as
previously described (14, 23). The Ery-resistant (Eryr) transformants were grown and selected on MH
plates containing 5 g/ml Ery. Two independent natural transformation experiments were performed,
leading to two libraries composed of approximately 1,000 and 2,500 Eryr colonies, respectively, in each
transformation experiment.
Step 2, comparative conjugation. We modiﬁed our previous biparental conjugation protocol (23)
to screen the NCTC 11168-derived Eryr (chuB::erm) transformants that potentially display the HFC
phenotype. Each conjugation experiment was performed in two independent experiments with dupli-
cate measurements in each experiment. In brief, the Eryr C. jejuni transformants from each library were
harvested from plates using MH broth and mixed well. Approximately 500 l of the Eryr C. jejuni
transformant suspension (optical density at 600 nm, around 10) was used as the recipient and mixed with
500 l of the logarithmic-phase E. coli donor strain JL1116 (optical density at 600 nm, around 1.2)
containing shuttle vector pRY107 and the RK212.1 helper plasmid (23). The mixture was then pelleted
down, resuspended in 100 l of MH broth, and then spotted onto MH agar plate and incubated for 7 h
under microaerophilic conditions. Following incubation, the mixed C. jejuni and E. coli cells were
harvested from MH agar plates using 700 l MH broth. The cell suspension was serially diluted (10-fold)
in MH broth and differentially plated onto two types of MH plates, with one containing Campylobacter-
speciﬁc selective antibiotics (SR117E; Oxoid) to recover the total C. jejuni recipient cells, and the other
containing selective antibiotics (SR117E; Oxoid) plus kanamycin (50 g/ml) to recover the C. jejuni
transconjugants containing the pRY107 plasmid. The conjugation efﬁciency was determined on the basis
of transconjugant CFU per recipient. As a control, the wild-type NCTC 11168 that displayed LFC
phenotype was used and subjected to the same conjugation procedure detailed above. The NCTC
11168-derived Eryr transformants, due to containing a population of potential HFC transformants, were
expected to display signiﬁcantly higher conjugation efﬁciency than the control NCTC 11168. Speciﬁcally,
the kanamycin-resistant transconjugants observed at the dilution at which no single transconjugant was
observed in control strain potentially acquire an HFC phenotype. The transconjugants of interest were
picked and subjected to validation as described below.
Validation of conjugation efﬁciency. To determine if the transconjugants resulted from HFC
transformants, the shuttle vector pRY107 that confers kanamycin resistance was cured from each
transconjugant. Brieﬂy, each transconjugant was puriﬁed, inoculated into antibiotic-free MH broth, and
passaged every other day for 2 weeks. The culture was then serially diluted in MH broth and plated on
MH plates to retrieve isolated colonies. A panel of colonies were individually picked and replicated onto
plain MH agar plates and MH agar plates containing kanamycin (50 g/ml); the colonies that did not
grow in the presence of kanamycin were desired plasmid-cured strains. These plasmid-cured strains were
subsequently used as recipient strains for conjugation efﬁciency evaluation by performing the biparental
conjugation experiment as described before (23). Each conjugation efﬁciency measurement was per-
formed in two independent experiments, with duplicate measurements in each experiment.
Genome sequencing and comparative genomic analysis. Genomic DNA from eight selected
plasmid-cured strains was extracted using the Wizard genomic DNA puriﬁcation kit (Promega) and
puriﬁed using the Genomic DNA Clean & Concentrator kit (Zymo Research). Genomic DNA was se-
quenced using the MiSeq platform at the Iowa State University DNA Facility, where genomic DNA was
end repaired, ligated to speciﬁc adaptors, and subject to paired-end sequencing. After ﬁltering raw reads,
the clean reads were de novo assembled into contigs using the CLC Genomics Workbench. The contigs
were aligned against reference genome C. jejuni NCTC 11168 (38, 44) for comparative analysis by using
Mauve (version 2.3.0) (45, 46).
Inactivation of Cj1051c. The Cj1051c (CjeI) gene was inactivated via allelic exchange using a suicide
vector, as described previously (47–49). Brieﬂy, approximately 4.6 kb of Cj1051c fragment was ampliﬁed
from C. jejuni NCTC 11168 using PfuUltra II fusion HS DNA polymerase (Stratagene) and the CjeI_F/CjeI_R
primer pair (Table 3), and cloned into SmaI-digested pUC19. The pUC19-CjeI recombinant plasmid was
digested with SwaI and then ligated with a blunt-end chloramphenicol resistance cassette, cat (42). The
resulting suicide vector, in which the orientation of cat is the same as that of CjeI (detected with
CjeI_F1/Cm_Seq_R [Table 3]), was introduced into C. jejuni NCTC 11168 via natural transformation (14).
Transformants were selected on an MH plate containing 6 g/ml chloramphenicol, and the insertional
mutation was conﬁrmed by PCR using the primer pairs CjeI_F1/CjeI_R1 and CjeI_F1/Cm_Seq_R (Table 3).
Chromosomal complementation of CjeI. The chromosomal complementation in the ribosomal
sites was performed using strategy similar to that in a previous report (32), except a multiple-cloning site
(MCS) was introduced in the chromosomal integration vector. The cloning process was illustrated in Fig.
3. First, approximately 1.9 kb of rrs fragment was ampliﬁed from C. jejuni NCTC 11168 using PfuUltra II
fusion HS DNA polymerase (Stratagene) and primer pair rrsF (NdeI)/rrsR (SphI) (Table 3), and cloned into
NdeI/SphI-digested pUC19, in which the MCS was removed by NdeI/SphI digestion. The resulting
recombinant plasmid, pCjR, was digested with XbaI and MfeI and then ligated with annealed oligonu-
cleotides pCjR_MCS_F1 and pCjR_MCS_R1, which introduce MCS (EcoRI-SacI-KpnI-BamHI-SalI-PstI-AfeI)
into pCjR, resulting in the plasmid pCjR-MCS. Because CjeI is located within an operon and probably does
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not have an immediate adjacent promoter, a Cj0299 overexpression promoter from a beta-lactamase-
resistant NCTC 11168 transformant JL974 (50) was ampliﬁed with the Cj0299_pMW10_F (XbaI)/
Cj0299_pMW10_R1 (KpnI) primer pair, digested with XbaI/KpnI, and ligated with XbaI/KpnI-digested
pCjR-MCS, resulting in plasmid pRO. The chloramphenicol resistance cassette cat (42) was ampliﬁed with
the Cm_F (MfeI)/Cm_R (MfeI) primer pair, digested with MfeI, and ligated into MfeI-digested pRO,
resulting in plasmid pROC. The cloning of the Cj0299 overexpression promoter and chloramphenicol
resistance cassette cat into pCjR was conﬁrmed by PCR (using the rrs_Seq_F/rrs_Seq_R and rrs_Seq_F/
Cm-Seq_R primer pairs) and Sanger sequencing. The 4.1-kb fragment containing the whole ORF of CjeI
was ampliﬁed with the CjeI_F4 (KpnI)/CjeI_R4 (BamHI) primer pair, digested with KpnI/BamHI, and ligated
into KpnI/BamHI-digested pROC. The cloning of CjeI into pROC was conﬁrmed by PCR (using the
CjeI_F_Seq/Cm-Seq_R primer pair) and Sanger sequencing. The resulting suicide vector, pROC-CjeI, was
introduced into C. jejuni Cj8486 and NCTC 11168 HFC transformants 11 and 12 via electroporation.
Transformants were selected on an MH plate containing 6 g/ml chloramphenicol, and the insertion of
CjeI was conﬁrmed by PCR using the CjeI_F_Seq/Cm-Seq_R primer pair (Table 3).
Production of recombinant CjeI. Histidine-tagged recombinant CjeI (rCjeI) was produced in E. coli
using pET serial vectors. Brieﬂy, a 4,017-bp fragment covering the full length of CjeI (amino acids [aa] 1
to 1339) was ampliﬁed from C. jejuni NCTC 11168 using the CjeI_F5 (NdeI)/CjeI_R5 (SalI) primer pair (Table
3). The NdeI/SalI doubly digested CjeI PCR product and expression vectors (pET-21b or pET-28b) were
ligated and transformed into E. coli BL21(DE3). The pET-21b derivative clone (JL1165), which produces
C-terminal-6His (C-6His)-tagged rCjeI, or the pET-28b derivative clone (JL1166), which produces
6His-tagged rCjeI at both ends, was sequenced to conﬁrm no errors. At ﬁrst, the expression of both
constructs was evaluated under normal conditions (3 h of incubation after adding 0.5 mM IPTG at 37°C).
To increase the solubility of rCjeI, the expression of rCjeI from JL1166 was performed at 4°C for 3 days.
Cell pellets were lyzed by incubation with lysozyme, followed by sonication. The soluble fraction
containing rCjeI was puriﬁed using the procedures described in our previous publication (29). The eluted
fractions containing pure rCjeI were pooled and dialyzed against buffer of 1 phosphate-buffered saline
(PBS) with 10% glycerol. The concentration of the puriﬁed rCjeI was determined using a bicinchoninic
acid (BCA) assay (51) and was aliquoted for storage at 80°C.
Endonuclease activity of rCjeI. The assay for the endonuclease activity of rCjeI was performed in the
volume of 50 l composed of 2.25 g of puriﬁed rCjeI, 3 g of shuttle vector pRY107, 50 mM potassium
acetate, 20 mM Tris-acetate (pH 7.9), 10 mM magnesium acetate, 1 mM dithiothreitol (DTT), 100 g/ml
bovine serum albumin (BSA; NEB), and 80 M S-adenosyl-methionine (catalog no. B9003S; NEB). The
reaction mixture was incubated at 37°C; samples were taken at different time points, followed by
immediate heat inactivation of rCjeI at 65°C for 15 min. The samples were subjected to agarose gel
electrophoresis for examination of hydrolysis of pRY107 by rCjeI. When required, puriﬁed rCjeI was heat
treated (at 50°C) before being added to the reaction mixture.
Data availability. The sequences of the eight Eryr NCTC 11168 transformants (Table 1) have been
deposited into GenBank under BioProject PRJNA428364.
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